期刊文献+

Epidemiological aspects of Budd-Chiari in Egyptian patients:A single-center study 被引量:2

Epidemiological aspects of Budd-Chiari in Egyptian patients:A single-center study
在线阅读 下载PDF
导出
摘要 AIM: TO describe the socio-demographic features, etiology, and risk factors for Budd-Chiari syndrome (BCS) in Egyptian patients. METHODS: Ninety-four Egyptian patients with confirmed primary Budd-Chiari syndrome were presented to the Budd-Chiari Study Group (BCSG) and admitted to the Tropical Medicine Department of Ain Shams University Hospital (Cairo, Egypt). Complete clinical evaluation and laboratory investigations, including a thrombophilia workup and full radiological assessment, were performed to determine underlying disease etiologies.RESULTS: BCS was chronic in 79.8% of patients, acute or subacute in 19.1%, and fulminant in 1.1%. Factor V Leiden mutation (FVLM) was the most common etiological cause of disease (53.1%), followed by mutation of the gene encoding methylene tetrahydrofolate reductase (MTHFR) (51.6%). Current or recent hormonal treatment was documented in 15.5% of females, and BCS associated with pregnancy was present in 17.2% of females. Etiology could not be determined in 8.5% of patients. Males had significantly higher rates of MTHFR gene mutation and Behcet' s disease, and females had significantly higher rates of secondary antiphospholipid antibody syndrome. A highly significant positive relationship was evident between the presence of Behcet's disease and inferior vena caval occlusion, either alone or combined with occlusion of the hepatic veins (,0 〈 0.0001). CONCLUSION: FVLM is the most common disease etiology and MTHFR the second most common in Egyptian BCS patients. BCS etiology tends to vary with geographic region. AIM:To describe the socio-demographic features,etiology,and risk factors for Budd-Chiari syndrome(BCS) in Egyptian patients.METHODS:Ninety-four Egyptian patients with confirmed primary Budd-Chiari syndrome were presented to the Budd-Chiari Study Group(BCSG) and admitted tothe Tropical Medicine Department of Ain Shams University Hospital(Cairo,Egypt) . Complete clinical evaluation and laboratory investigations,including a throm bophiliaworkup and full radiological assessment,were performed to determine underlying disease etiologies.RESULTS:BCS was chronic in 79.8% of patients,acute or subacute in 19.1%,and fulminant in 1.1%.Factor V Leiden mutation(FVLM) was the most common etiological cause of disease(53.1%) ,followed by mutation of the gene encoding methylene tetra-hydrofolate reductase(MTHFR) (51.6%) . Current orrecent hormonal treatment was documented in 15.5%of females,and BCS associated with pregnancy was present in 17.2% of females. Etiology could not be determined in 8.5% of patients. Males had significantly higher rates of MTHFR gene mutation and Beh et's disease,and females had significantly higher ratesof secondary antiphos pholipid antibody syndrome.A highly significant positive relation ship was evident between the presence of Beh et's disease and inferiorven a caval occlusion,either alone or combined with occlusion of the hepatic veins(P < 0.0001) .CONCLUSION:FVLM is the most common disease etiology and MTHFR the second most common in Egyptian BCS patients. BCS etiology tends to vary with geographic region.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第42期4704-4710,共7页 世界胃肠病学杂志(英文版)
关键词 Budd-Chiari syndrome Epidemiological aspects ETIOLOGY Factor V Leiden mutation Methylene tetrahydrofolate reductase gene mutation 患者 埃及 流行病学 亚甲基四氢叶酸还原酶 MTHFR 基因突变 BCS 凝血因子V
  • 相关文献

参考文献1

二级参考文献19

  • 1[1]Menon KV,Shah V,Kamath PS.The Budd-Chiari syndrome.N Engl J Med 2004; 350:578-585
  • 2[2]Janssen HL,Meinardi JR,Vleggaar FP,van Uum SH,Haagsma EB,van Der Meer FJ,van Hattum J,Chamuleau RA,Adang RP,Vandenbroucke JP,van Hoek B,Rosendaal FR.Factor V Leiden mutation,prothrombin gene mutation,and deficiencies in coagulation inhibitors associated with BuddChiari syndrome and portal vein thrombosis:results of a casecontrol study.Blood 2000; 96:2364-2368
  • 3[3]Denninger MH,Chait Y,Casadevall N,Hillaire S,Guillin MC,Bezeaud A,Erlinger S,Briere J,Valla D.Cause of portal or hepatic venous thrombosis in adults:the role of multiple concurrent factors.Hepatology 2000; 31:587-591
  • 4[4]Hirshberg B,Shouval D,Fibach E,Friedman G,Ben-Yehuda D.Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome.J Hepato12000; 32:574-578
  • 5[5]Deltenre P,Denninger MH,HiUaire S,Guillin MC,Casadevall N,Briere J,Erlinger S,Valla DC.Factor V Leiden related Budd-Chiari syndrome.Gut 2001; 48:264-268
  • 6[6]Bismuth E,Hadengue A,Hammel P,Benhamou JP.Hepatic vein thrombosis in Behcet's disease.Hepatology 1990; 11:969-974
  • 7[7]Shrestha SM,Okuda K,Uchida T,Maharjan KG,Shrestha S,Joshi BL,Larsson S,Vaidya Y.Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal.J Gastroenterol Hepatol 1996; 11:170-179
  • 8[8]Mohanty D,Shetty S,Ghosh K,Pawar A,Abraham P.Hereditary thrombophilia as a cause of Budd-Chiari syndrome:a study from Western India.Hepatology 2001; 34:666-670
  • 9[9]Okuda H,Yamagata H,Obata H,Iwata H,Sasaki R,Imai F,Okudaira M,Ohbu M,Okuda K.Epidemiological and clinical features of Budd-Chiari syndrome in Japan.J Hepatol 1995; 22:1-9
  • 10[10]Hadengue A,Poliquin M,Vilgrain V,Belghiti J,Degott C,Erlinger S,Benhamou JP.The changing scene of hepatic vein thrombosis:recognition of asymptomatic cases.Gastroenterology 1994; 106:1042-1047

共引文献13

同被引文献22

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部